Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1996
10/22/1996CA1338659C Method of healing wounds in horses
10/22/1996CA1338658C Method and compositions for treatment of trauma-associated sepsis with gamma interferon
10/20/1996CA2172884A1 Method for preventing a second heart attack employing an hmg coa reductase inhibitor
10/17/1996WO1996032495A1 Monoclonal antibody specific for human 4-1bb and cell line producing same
10/17/1996WO1996032494A1 Fusion protein delivery system and uses thereof
10/17/1996WO1996032485A1 Phospholipase c homolog
10/17/1996WO1996032483A1 Immune-evading proteins
10/17/1996WO1996032482A1 Bacteriocins
10/17/1996WO1996032481A1 New chemokine expressed in eosinophils
10/17/1996WO1996032478A1 Altered polypeptides with increased half-life
10/17/1996WO1996032474A1 Cooperative oligonucleotides
10/17/1996WO1996032473A1 Dumbbell sense oligonucleotide for inhibiting herpes simplex virus (hsv)
10/17/1996WO1996032471A2 Atp-diphosphohydrolases, process of purification thereof and process of producing thereof by recombinant technology
10/17/1996WO1996032418A1 Anti-cd14 antibodies for use in the induction of il-10 secretion
10/17/1996WO1996032416A1 Novel anti-aids immunotoxins
10/17/1996WO1996032415A1 Platelet aggregation inhibitors containing c-terminal aminergic side chain amino acid residues
10/17/1996WO1996032414A1 Glucagon-like peptide-2 and its therapeutic use
10/17/1996WO1996032413A1 Process for the purification of glycoproteins like erythropoietin
10/17/1996WO1996032412A1 PEPTIDE SUPPRESSING IxBα PHOSPHORYLATION
10/17/1996WO1996032411A1 Binding sites for phosphotyrosine binding domains
10/17/1996WO1996032408A1 Novel 4-substituted-3-peptidyl-azetidin-2-one derivatives useful as cysteine proteinase inhibitor
10/17/1996WO1996032380A1 Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors
10/17/1996WO1996032152A1 Pulmonary administration of dry powder alpha 1-antitrypsin
10/17/1996WO1996032149A1 Pulmonary delivery of aerosolized medicaments
10/17/1996WO1996032140A1 Methods for engineering artificial veto cells
10/17/1996WO1996032139A1 Method for in vivo regulation of cardiac muscle contractility
10/17/1996WO1996032138A1 Methods for treating respiratory disease
10/17/1996WO1996032137A2 Methods of inducing immune tolerance using immunotoxins
10/17/1996WO1996032131A1 USE OF TGF-β3 TO REDUCE THE FORMATION OF SCAR TISSUE IN RESPONSE TO CORNEAL TRAUMA
10/17/1996WO1996032130A1 The use of cross-linked hemoglobin in treating subarachnoid hemorrhage
10/17/1996WO1996032129A1 Synthetic peptides that inhibit leukocyte superoxide anion production and/or attract leukocytes
10/17/1996WO1996032128A1 Isolated 55 to 75 kda protein which binds to prion protein
10/17/1996WO1996032127A1 Methods of enhancing epithelial cell proliferation
10/17/1996WO1996032126A1 Analogs of growth hormone-releasing factor
10/17/1996WO1996032125A1 Methods for treating motor deficits
10/17/1996WO1996032124A1 Modified lysine or arginine containing proteins and peptides
10/17/1996WO1996032123A1 Pharmaceutical preparations derived from korean mistletoe
10/17/1996WO1996032121A1 Pharmaceutical preparations derived from european mistletoe
10/17/1996WO1996032119A1 Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of gvhd
10/17/1996WO1996032115A1 A pharmaceutical composition containing n-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers
10/17/1996WO1996032111A1 Trapidil for use in the treatment of immuno-modulatorily influencible cases
10/17/1996WO1996032102A1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
10/17/1996WO1996032096A1 Powdered pharmaceutical formulations having improved dispersibility
10/17/1996WO1996032087A2 Transgenic fish in the treatment of diabetes
10/17/1996WO1996028185A3 Composition containing amlodipine, or a salt, or felodipine and an ace inhibitor
10/17/1996WO1996027006A3 Human vegf-specific antisense oligonucleotides
10/17/1996WO1996025491A3 Inhibition of proliferation of vascular smooth muscle cell
10/17/1996WO1996023066A3 Prostaglandin receptor, dp
10/17/1996WO1996022371A3 C-C CHEMOKINE RECEPTOR 3: CKP-3 OR Eos-L2
10/17/1996WO1996022308A3 Appetite suppression factor and related methods
10/17/1996WO1996021020A3 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
10/17/1996WO1996020725A3 Peptide, peptide analog and amino acid analog protease inhibitors
10/17/1996WO1996017951A3 Identification of genes responsible for in vivo survival of microorganisms
10/17/1996WO1996016173A3 Modified proteinase inhibitors
10/17/1996WO1996016084A3 A method of identifying cftr-binding compounds useful for activating chloride conductance in animal cells
10/17/1996DE19514048A1 Trapidil zur Verwendung in der Therapie von immunmodulatorisch beeinflußbaren Krankheitsbildern Trapidil for use in the treatment of immunomodulatory influenced diseases
10/17/1996DE19513855A1 Use of polyethylene glycol-hirudin to treat unstable angina pectoris
10/17/1996DE19512484A1 Kohlenhydratmodifizierte Cytostatika Carbohydrate-modified cytostatics
10/17/1996CA2218225A1 Glucagon-like peptide-2 and its therapeutic use
10/17/1996CA2218208A1 Pulmonary administration of dry powder alpha 1-antitrypsin
10/17/1996CA2218173A1 Analogs of growth hormone-releasing factor
10/17/1996CA2217977A1 Immune-evading proteins
10/17/1996CA2217951A1 A pharmaceutical composition containing n-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers
10/17/1996CA2217947A1 Isolated 55 to 75 kda protein which binds to prion protein
10/17/1996CA2217025A1 New chemokine expressed in eosinophils
10/17/1996CA2216996A1 Platelet aggregation inhibitors containing c-terminal aminergic side chain amino acid residues
10/17/1996CA2216858A1 Phospholipase c homolog
10/17/1996CA2216210A1 Novel anti-aids immunotoxins
10/17/1996CA2215389A1 Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of gvhd
10/17/1996CA2212356A1 Novel 4-substituted-3-peptidyl-azetidin-2-one derivatives useful as cysteine proteinase inhibitor
10/17/1996CA2192597A1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
10/17/1996CA2191969A1 Transgenic fish in the treatment of diabetes
10/17/1996CA2191952A1 The use of cross-linked hemoglobin in treating subarachnoid hemorrhage
10/16/1996EP0737750A2 Expression of exogenous polynucleotide sequences in a vertebrate
10/16/1996EP0737747A2 Cytoplasmatic expression in E. coli of antibodies, antibody fragments and fusions thereof
10/16/1996EP0737691A1 Bombesin analogs
10/16/1996EP0737690A2 Antihypertensive agent and method for preparing same
10/16/1996EP0737252A1 Gene therapy vector for the treatment of low or defective red blood cell production
10/16/1996EP0737251A1 Antibodies to egf receptor and their antitumour effect
10/16/1996EP0737250A1 Humanized antibodies and uses thereof
10/16/1996EP0737249A1 Tumor suppressor protein prb2, related gene products, and dna encoding therefor
10/16/1996EP0737248A1 Gene expression control
10/16/1996EP0737247A1 Method and reagent for inhibiting hepatitis c virus replication
10/16/1996EP0737207A1 Inhibitors of human plasmin derived from the kunitz domains
10/16/1996EP0737206A1 Glucagon analogs with serine replacements at position 16 having antagonistic activity
10/16/1996EP0737205A1 T-cell epitopes
10/16/1996EP0737204A1 Cs-1 peptidomimetics, compositions and methods of using the same
10/16/1996EP0737085A1 VACCINE FOR $i(BRANHAMELLA CATARRHALIS)
10/16/1996EP0737076A1 Method for antigen-specific immunoregulation by t-cell alpha chain
10/16/1996EP0737075A1 Ileal bile acid transporter compositions and methods
10/16/1996EP0737074A1 Botulinum toxins for treating various disorders and associated pain
10/16/1996EP0737073A1 Novel peptides for heparin and low molecular weight heparin anticoagulation reversal
10/16/1996EP0601062B1 Sirs vaccine and diagnosis method
10/16/1996EP0601052B1 Therapeutic method for the treatment of iddm
10/16/1996EP0597007B1 W/o microemulsions
10/16/1996EP0547223B1 Remedy for corneal damages
10/16/1996EP0543945B1 Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus
10/16/1996EP0432168B1 Genetically engineered coccidiosis vaccine
10/16/1996CN1133616A A novel nuclear mitotic phosphoprotein:mitosin
10/16/1996CN1133599A Recombinant IL4 antibodies useful in treatment of IL4 mediated disorders
1 ... 2760 2761 2762 2763 2764 2765 2766 2767 2768 2769 2770 2771 2772 2773 2774 2775 2776 2777 2778 2779 2780 ... 3163